1. Home
  2. Labeler Index
  3. Acorda Therapeutics, Inc.
  4. 10144-342
  5. NDC Package Code: 10144-342-04 Inbrija

NDC Package 10144-342-04 Inbrija

Levodopa Capsule Respiratory (inhalation) - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
10144-342-04
Package Description:
1 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)
Product Code:
10144-342
Proprietary Name:
Inbrija
Non-Proprietary Name:
Levodopa
Substance Name:
Levodopa
Usage Information:
This medication is used when needed to treat the return of Parkinson's symptoms (known as OFF episodes) in people with Parkinson's disease who are treated with carbidopa/levodopa medicines. Parkinson's disease tends to worsen over time, and you may need extra levodopa from time to time to keep symptoms (such as shakiness, stiffness, difficulty moving) from returning. This medication does not replace your regular carbidopa/levodopa medicine. Keep taking your carbidopa/levodopa medicine regularly as directed by your doctor. Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement.
11-Digit NDC Billing Format:
10144034204
NDC to RxNorm Crosswalk:
  • RxCUI: 2107616 - levodopa 42 MG Inhalation Powder Capsule
  • RxCUI: 2107616 - levodopa 42 MG Inhalation Powder
  • RxCUI: 2107616 - L-DOPA 42 MG Inhalation Powder
  • RxCUI: 2107621 - Inbrija 42 MG Inhalation Powder Capsule
  • RxCUI: 2107621 - levodopa 42 MG Inhalation Powder [Inbrija]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Acorda Therapeutics, Inc.
    Dosage Form:
    Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
    Administration Route(s):
  • Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
    • Active Ingredient(s):
  • LEVODOPA 42 mg/1
    • Pharmacologic Class(es):
  • Amino Acids, Aromatic - [CS]
  • Aromatic Amino Acid - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA209184
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    12-22-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    10144-342-123 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)
    10144-342-164 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)
    10144-342-328 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)
    10144-342-6015 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)
    10144-342-9223 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 10144-342-04?

    The NDC Packaged Code 10144-342-04 is assigned to a package of 1 blister pack in 1 carton / 4 capsule in 1 blister pack (10144-342-01) of Inbrija, a human prescription drug labeled by Acorda Therapeutics, Inc.. The product's dosage form is capsule and is administered via respiratory (inhalation) form.

    Is NDC 10144-342 included in the NDC Directory?

    Yes, Inbrija with product code 10144-342 is active and included in the NDC Directory. The product was first marketed by Acorda Therapeutics, Inc. on December 22, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 10144-342-04?

    The 11-digit format is 10144034204. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-210144-342-045-4-210144-0342-04